TORONTO — The exhibit each hand as they are called has been
“postponed indefinitely” and won’t be part of Luminato, the Toronto art
festival said last week.Kensington Exhibit ‘Postponed Indefinitely’
TORONTO — The exhibit each hand as they are called has been “postponed indefinitely” and won’t be part of Luminato, the Toronto art festival said last week.
Last month, the Koffler Centre of the Arts said it was disassociating, but not pulling funding, from the interactive exhibit about the history of Toronto’s Kensington Market after it said it learned the artist, Reena Katz, supports Israeli Apartheid Week. It gave the exhibit $20,000 and co-sponsored it with Luminato.
Baycrest, whose seniors were integral to the exhibit’s interactive component, withdrew its support just before the scheduled opening date of May 20, Katz said.
Luminato and Koffler are no longer promoting it.
Katz, who calls herself an anti-Zionist Jew, has said Koffler officials knew of her political leanings before they agreed to sponsor her project, and were comfortable with it, because it had nothing to do with the Middle East.
It was to have run in Kensington Market until July 26.
TORONTO — The Globe and Mail last week named its Report on Business (ROB) editor, John Stackhouse, as its editor-in-chief, replacing Edward Green-spon, who had helmed the paper since 2002. Greenspon previously served as the Globe’s ROB editor and its politics editor, and as editor-in-chief, he presided over a redesign of the Globe’s print and web editions. -Publisher Phillip Crawley said Greenspon, 52, was stepping down, but he didn’t give any reason for the change.
Dalfen Headed CRTC
TORONTO — Montreal-born lawyer Charles Dalfen, who championed Canadian content as chair of the Canadian Radio-television and Telecommunications Commission from 2002 to 2006, died May 26 from a heart attack at age 66. Dalfen presided over the CRTC in 2004 when it approved Al Jazeera for broadcast in Canada if cable and satellite carriers promised to censor hate speech on it, but they said the cost would be prohibitive.
Firms Get Grant
TORONTO — An Israeli firm and a Canadian company have received a grant from the Canada-Israel Industrial Research and Development Foundation (CIIRDF) to create products to assess the risk of pre-eclampsia, a potentially fatal condition for women and their fetuses during pregnancy. Diagnostic Technologies Ltd., which develops diagnostic devices for high-risk pregnancies, and Canadian partner, Miraculins Inc., got $782,000 toward their $1.6-million joint project, the companies said last week. The CIIRDF was formed in 1994 to promote collaborative research and development between Israeli and Canadian companies.